# Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age

Study · id `cardio:ct-nct06250257` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06250257](<https://clinicaltrials.gov/study/NCT06250257>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06250257

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 112 participants.

## Technical summary

Registry record NCT06250257. Randomized; no masking; primary purpose treatment. Start 2024-10-21 (actual); primary completion 2026-05-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 112 participants (planned count; ClinicalTrials.gov record NCT06250257, source copy `cardio:ctgov-nct06250257-2024-11-19`, retrieved 2026-10-31)
- Started: 2024-10-21 (actual) (ClinicalTrials.gov record NCT06250257, source copy `cardio:ctgov-nct06250257-2024-11-19`, retrieved 2026-10-31)
- Primary completion: 2026-05-30 (anticipated) (ClinicalTrials.gov record NCT06250257, source copy `cardio:ctgov-nct06250257-2024-11-19`, retrieved 2026-10-31)
- Completion: 2026-11-30 (anticipated) (ClinicalTrials.gov record NCT06250257, source copy `cardio:ctgov-nct06250257-2024-11-19`, retrieved 2026-10-31)
- Countries: Ethiopia (ClinicalTrials.gov record NCT06250257, source copy `cardio:ctgov-nct06250257-2024-11-19`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06250257-2024-11-19`, retrieved 2026-10-31)

## The registry's words

- Brief title: Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age
- Condition: Dilated Cardiomyopathy
- Intervention (Drug): Bromocriptine mesylate plus standard GDMT
- Lead sponsor: Jimma University
- Lead sponsor class: OTHER
- Collaborator: Ludwig-Maximilians - University of Munich
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Dilated cardiomyopathy (`cardio:dilated-cardiomyopathy`)
- Registry lists this organization as a collaborator: Ludwig-Maximilians - University of Munich (`cardio:org-ludwig-maximilians-university-of-munich`)

## Provenance

Content hash: fa29cc350203e52be455ceff22ad0d08a0a207877c8e8f3236a4b0f6a5133029
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
